Post Hoc Analyses of Randomized Clinical Trial for the Effect of Clopidogrel Added to Aspirin on Kidney Function | Zendy

Jesse C. Ikeme | Zendy; Pablo E. Pérgola | Zendy; Rebecca Scherzer | Zendy; Michael G. Shlipak | Zendy; Oscar Benavente | Zendy; Carmen A. Peralta | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Post Hoc Analyses of Randomized Clinical Trial for the Effect of Clopidogrel Added to Aspirin on Kidney Function

Author(s) -

Jesse C. Ikeme,

Pablo E. Pérgola,

Rebecca Scherzer,

Michael G. Shlipak,

Oscar Benavente,

Carmen A. Peralta

Publication year - 2017

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.00100117

Subject(s) - medicine , aspirin , clopidogrel , post hoc analysis , randomized controlled trial , post hoc , renal function , clinical trial , cardiology

Despite the high burden of CKD, few specific therapies are available that can halt disease progression. In animal models, clopidogrel has emerged as a potential therapy to preserve kidney function. The effect of clopidogrel on kidney function in humans has not been established.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research